一个容易吞的药丸:为21世纪提供口服复合疫苗

Molly R Braun1, Becca A Flitter1, William Sun1

  • 1Vaxart, Inc., 170 Harbor Way STE 300, South San Francisco, CA 94080, USA.

PubMed
概括

使用非复制性腺病毒5型载体的下一代口服疫苗显示出更强的粘膜免疫力. 这些复合腺病毒5型 (rAd5) 疫苗为流感和SARS-CoV-2等疾病提供了潜在的公共卫生益处.

相关概念视频

Recombinant DNA01:09

Recombinant DNA

Overview
95.9K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
54
Vaccinations01:51

Vaccinations

Overview
44.7K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
403
The Central Dogma01:20

The Central Dogma

The central dogma explains the flow of genetic information from DNA nucleotides to the amino acid sequence of proteins.
RNA is the Missing Link Between DNA and Proteins
In the early 1900s, scientists discovered that DNA stores all the information needed for cellular functions and that proteins perform most of these functions. However, the mechanisms of converting genetic information into functional proteins remained unknown for many years. Initially, it was believed that a single gene is...
21.8K
Cross-reactivity00:42

Cross-reactivity

Overview
31.3K